Jitka Malcikova

Brno, JM, Czech Republic

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications

Longitudinal single-cell analysis reveals dynamic clonal competition and convergent evolution shaped by therapy sequencing in a young patient with chronic lymphocytic leukemia.

Longitudinal single-cell analysis reveals dynamic clonal competition and convergent evolution shaped by therapy sequencing in a young patient with chronic lymphocytic leukemia.

Journal: Haematologica
Published: May 15, 2026

Detection of clinically relevant variants in the TP53 gene below 10% allelic frequency: A multicenter study by ERIC, the European Research Initiative on CLL.

Detection of clinically relevant variants in the TP53 gene below 10% allelic frequency: A multicenter study by ERIC, the European Research Initiative on CLL.

Journal: HemaSphere
Published: July 11, 2024

ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-2024 update.

ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-2024 update.

Journal: Leukemia
Published: January 04, 2024

Unveiling the dynamics and molecular landscape of a rare chronic lymphocytic leukemia subpopulation driving refractoriness: insights from single-cell RNA sequencing.

Unveiling the dynamics and molecular landscape of a rare chronic lymphocytic leukemia subpopulation driving refractoriness: insights from single-cell RNA sequencing.

Journal: Molecular oncology
Published: December 14, 2023

Integrative NGS testing reveals clonal dynamics of adverse genomic defects contributing to a natural progression in treatment-naïve CLL patients.

Integrative NGS testing reveals clonal dynamics of adverse genomic defects contributing to a natural progression in treatment-naïve CLL patients.

Journal: British journal of haematology
Published: July 25, 2023

Editorial: Biology and treatment of high-risk CLL.

Editorial: Biology and treatment of high-risk CLL.

Journal: Frontiers in oncology
Published: November 28, 2022

Opinion: What defines high-risk CLL in the post-chemoimmunotherapy era?

Opinion: What defines high-risk CLL in the post-chemoimmunotherapy era?

Journal: Frontiers in oncology
Published: November 23, 2022

Distinct p53 phosphorylation patterns in chronic lymphocytic leukemia patients are reflected in the activation of circumjacent pathways upon DNA damage.

Distinct p53 phosphorylation patterns in chronic lymphocytic leukemia patients are reflected in the activation of circumjacent pathways upon DNA damage.

Journal: Molecular oncology
Published: April 22, 2022

Evolution of TP53 abnormalities during CLL disease course is associated with telomere length changes.

Evolution of TP53 abnormalities during CLL disease course is associated with telomere length changes.

Journal: BMC cancer
Published: May 20, 2021

Low-burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment options.

Low-burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment options.

Journal: Blood
Published: October 18, 2020

PRIMA-1MET cytotoxic effect correlates with p53 protein reduction in TP53-mutated chronic lymphocytic leukemia cells.

PRIMA-1MET cytotoxic effect correlates with p53 protein reduction in TP53-mutated chronic lymphocytic leukemia cells.

Journal: Leukemia research
Published: October 01, 2019

ATM and TP53 mutations show mutual exclusivity but distinct clinical impact in mantle cell lymphoma patients.

ATM and TP53 mutations show mutual exclusivity but distinct clinical impact in mantle cell lymphoma patients.

Journal: Leukemia & lymphoma
Published: January 11, 2019
Showing 1-12 of 46

Last Updated: 09/26/2026